House Subcommittee Recommends $137.7 Million Increase For NCI
In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute
NCI Names Brawly Director of Office of Special Populations
Owens Becomes President, NCCR
FDA approves Irinotecan, Days After ODAC Meeting
ODAC Recommends FDA Approval For Grain Tumor Implant
Letter: Headline Criticized On Letter About Consortium
Trending Stories
- Cancer clinical trials shouldn’t discriminate—but they do
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?
- In the aftermath of Helene and Milton, oncologists resort to airlifts to keep treatments on schedule
Helene knocks out Baxter facility, creating shortage of IV fluids - ACS board member Wayne Frederick steps in as interim CEO, replacing Karen Knudsen
National search will be conducted - Latino oncology leaders discuss representation in clinical trials, translational research, and health care
Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”